Scot Garg

Showing 1-20 of 27 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Coronary interventions

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Edes I, van de Harst P, Krackhardt F, Thijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

March 17, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Interventional cardiology: review of the year 2017

Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, Katagiri Y, Soliman O, Garg S, Onuma Y, Serruys P

April 20, 2018 | 10.4244/EIJ-D-18-00066

Coronary interventions

How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis?

Ormerod J, Lim J, Chandrasekaran B, Ramcharitar S, Garg S, Singh R, McDonald J, Balachandran K, Wykrzykowska J

January 20, 2016 | 10.4244/EIJV11I9A217

The FIREHAWK® stent: will it achieve its potential?

Garg S

May 21, 2013 | 10.4244/EIJV9I1A2

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P

November 30, 2011 | 10.4244/EIJV7I7A134

How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?

Gutiérrez-Chico J-L, Garcia-Garcia H, Ligthart J, Bol-Raap G, Garg S, Bekkers J, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A102

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A97

Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease

Gutiérrez-Chico J-L, Regar E, van Geuns R, Garg S, Schultz C, Van Mieghem N, Duckers H, Serruys P

June 30, 2011 | 10.4244/EIJV7I2A44

Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study

Garg S, Sarno G, Gutiérrez-Chico J-L, Garcia-Garcia H, Gomez-Lara J, Serruys P

April 20, 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P

April 20, 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

March 21, 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P

March 21, 2011

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

Legrand V, Garg S, Serruys P, Virtanen K, Szurawitzki G, Voudris V, Fontanelli A, Endersen K, Kranjec I, Rademaker T, Stefanadis C, Wittebols K

February 21, 2011

A comparison of the distribution of necrotic core in bifurcation and non-bifurcation coronary lesions: an in vivo assessment using intravascular ultrasound radiofrequency data analysis

Garcia-Garcia H, Gomez-Lara J, Gonzalo N, Garg S, Shin E, Goedhart D, Serruys P

August 15, 2010

The coronary Stent-On-A-Wire (SOAW)

Sarno G, Okamura T, Gomez-Lara J, Garg S, Girasis C, Kopia G, Pomeranz M, Easterbrook W, van Geuns R, van der Giessen WJ, Serruys P

August 15, 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

Serruys P, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann K, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, Drijver A-M, Otake H, Meredith L, Toyloy S, Fitzgerald P

June 30, 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

June 30, 2010

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Scot Garg

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke